I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model

AIMS: Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy, diastolic dysfunction and increased interstitial fibrosis. Current treatment is based on beta-adrenoceptor (AR) and calcium channel blockers. Since mice deficient of protein phosphatase-1 inhibitor-1 (I-1), an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cardiol Heart Vasc
Main Authors: Friedrich, Felix W., Sotoud, Hannieh, Geertz, Birgit, Weber, Silvio, Flenner, Frederik, Reischmann, Silke, Eschenhagen, Thomas, Carrier, Lucie, El-Armouche, Ali
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497269/
https://ncbi.nlm.nih.gov/pubmed/28785686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2015.05.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados